Rockefeller Capital Management’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Buy
6,651
+640
+11% +$23.4K ﹤0.01% 2573
2026
Q2
$237K Buy
6,011
+1,735
+41% +$69.9K ﹤0.01% 2512
2026
Q1
$190K Sell
4,276
-7,768
-64% -$343K ﹤0.01% 2529
2025
Q4
$506K Buy
+12,044
New +$509K ﹤0.01% 1894

Other funds holding MDLN

Rockefeller Capital Management's MDLN Position: Q3 2026 in Review

Rockefeller Capital Management increased its Medline (MDLN) stake by 11% in Q3 2026, buying an estimated $23.4K and bringing the position to 6,651 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Rockefeller Capital Management first reported a position in MDLN in Q4 2025 and has held it in 4 quarters since. The position peaked at $506K in Q4 2025. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Rockefeller Capital Management held 6,651 shares of Medline worth $231K as of Q3 2026.
  • Rockefeller Capital Management bought 640 Medline shares in Q3 2026, an estimated $23.4K.
  • Medline made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #2573 holding.
  • Rockefeller Capital Management first reported a position in Medline in Q4 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Medline position peaked at $506K in Q4 2025.
  • 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.